Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2009

Open Access 01-12-2009 | Case report

The subaortic tendon as a mimic of hypertrophic cardiomyopathy

Author: James Ker

Published in: Cardiovascular Ultrasound | Issue 1/2009

Login to get access

Abstract

Originally described by Brock and Teare, today hypertrophic cardiomyopathy is clinically defined as left (or right) ventricular hypertrophy without a known cardiac or systemic cause, such as systemic hypertension, Fabry's disease or aortic stenosis.
Also appreciated today is the enormous genotypic and phenotypic heterogeneity of this disease with more than 300 mutations over more than 24 genes, encoding various sarcomeric, mitochondrial and calcium-handling proteins, all as genetic causes for hypertrophic cardiomyopathy.
Phenotypically, the disease can vary from negligible to extreme hypertrophy, affecting either the left and/or right ventricle in an apical, midventricular or subaortic location.
Left ventricular false tendons are thin, fibrous or fibromuscular structures that traverse the left ventricular cavity. Recently, a case report was presented where it was shown that such a false tendon, originating from a subaortic location, was responsible for striking ST-segment elevation on the surface electrocardiogram.
In this case report, a case is presented where such a subaortic tendon led to the classic echocardiographic appearance of hypertrophic cardiomyopathy, thus in the assessment of hypertrophic cardiomyopathy, this entity needs to be excluded in order to prevent a false positive diagnosis of hypertrophic cardiomyopathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fifer MA, Vlahakes GJ: Management of symptoms in hypertrophic cardiomyopathy. Circulation 2008, 117: 429-439. 10.1161/CIRCULATIONAHA.107.694158CrossRefPubMed Fifer MA, Vlahakes GJ: Management of symptoms in hypertrophic cardiomyopathy. Circulation 2008, 117: 429-439. 10.1161/CIRCULATIONAHA.107.694158CrossRefPubMed
2.
go back to reference Brock R: Functional obstruction of the left ventricle: acquired aortic subvalvular stenosis. Guys Hosp Rep 1957, 106: 221-238.PubMed Brock R: Functional obstruction of the left ventricle: acquired aortic subvalvular stenosis. Guys Hosp Rep 1957, 106: 221-238.PubMed
3.
go back to reference Brock R: Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis). Guys Hosp Rep 1959, 108: 126-143.PubMed Brock R: Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis). Guys Hosp Rep 1959, 108: 126-143.PubMed
5.
go back to reference Bos JM, Ommen SR, Ackerman MJ: Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol 2007, 22: 193-199. 10.1097/HCO.0b013e3280e1cc7fCrossRefPubMed Bos JM, Ommen SR, Ackerman MJ: Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol 2007, 22: 193-199. 10.1097/HCO.0b013e3280e1cc7fCrossRefPubMed
6.
go back to reference Roberts R, Sigwart U: Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005, 112: 293-296. 10.1161/01.CIR.0000146788.30724.0ACrossRefPubMed Roberts R, Sigwart U: Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005, 112: 293-296. 10.1161/01.CIR.0000146788.30724.0ACrossRefPubMed
7.
go back to reference Shehata ML, Turkbey EB, Vogel-Claussen J, Bluemke DA: Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Top Magn Reson Imaging 2008, 19: 43-57. 10.1097/RMR.0b013e31816fcb22CrossRefPubMed Shehata ML, Turkbey EB, Vogel-Claussen J, Bluemke DA: Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Top Magn Reson Imaging 2008, 19: 43-57. 10.1097/RMR.0b013e31816fcb22CrossRefPubMed
8.
go back to reference Ramaraj R: Hypertrophic cardiomyopathy. Etiology, diagnosis and treatment. Cardiology in Review 2008, 16: 172-180. 10.1097/CRD.0b013e318178e525CrossRefPubMed Ramaraj R: Hypertrophic cardiomyopathy. Etiology, diagnosis and treatment. Cardiology in Review 2008, 16: 172-180. 10.1097/CRD.0b013e318178e525CrossRefPubMed
9.
go back to reference Nishimura RA, Ommen SR: Hypertrophic cardiomyopathy. The search for obstruction. Circulation 2006, 114: 2200-2202. 10.1161/CIRCULATIONAHA.106.660928CrossRefPubMed Nishimura RA, Ommen SR: Hypertrophic cardiomyopathy. The search for obstruction. Circulation 2006, 114: 2200-2202. 10.1161/CIRCULATIONAHA.106.660928CrossRefPubMed
10.
go back to reference Ackerman MJ: Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction? Curr Opin Cardiol 2005, 20: 175-181. 10.1097/01.hco.0000163668.44141.89CrossRefPubMed Ackerman MJ: Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction? Curr Opin Cardiol 2005, 20: 175-181. 10.1097/01.hco.0000163668.44141.89CrossRefPubMed
11.
go back to reference Kervancioglu M, Ozbag D, Kervancioglu P, Hatipoglu ES, Kiliuc M, Yilmaz F, Deniz M: Echocardiographic and morphologic examination of left ventricular false tendons in human and animal hearts. Clinical Anatomy 2003,16(5):389-395. 10.1002/ca.10152CrossRefPubMed Kervancioglu M, Ozbag D, Kervancioglu P, Hatipoglu ES, Kiliuc M, Yilmaz F, Deniz M: Echocardiographic and morphologic examination of left ventricular false tendons in human and animal hearts. Clinical Anatomy 2003,16(5):389-395. 10.1002/ca.10152CrossRefPubMed
12.
go back to reference Ker J: Sub-aortic tendon induced ST-segment elevation – a new echo-electrocardiographic phenomenon? Cardiovascular Ultrasound 2009, 7: 13. 10.1186/1476-7120-7-13CrossRefPubMedPubMedCentral Ker J: Sub-aortic tendon induced ST-segment elevation – a new echo-electrocardiographic phenomenon? Cardiovascular Ultrasound 2009, 7: 13. 10.1186/1476-7120-7-13CrossRefPubMedPubMedCentral
13.
go back to reference Shapiro LM, Howat AP, Crean PA, Westgate CJ: An echocardiographic study of localized subaortic hypertrophy. European Heart Journal 1986,7(2):127-132.PubMed Shapiro LM, Howat AP, Crean PA, Westgate CJ: An echocardiographic study of localized subaortic hypertrophy. European Heart Journal 1986,7(2):127-132.PubMed
14.
go back to reference Jategaonkar SR, Butz T, Burchert W, Horstkotte D, Faber L: Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma. Clin Res Cardiol 2009, 98: 195-198. 10.1007/s00392-009-0748-zCrossRefPubMed Jategaonkar SR, Butz T, Burchert W, Horstkotte D, Faber L: Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma. Clin Res Cardiol 2009, 98: 195-198. 10.1007/s00392-009-0748-zCrossRefPubMed
15.
go back to reference Symons C, Fortune F, Greenbaum RA, Dandona P: Cardiac hypertrophy, hypertrophic cardiomyopathy and hyperparathyroidism – an association. Br Heart J 1985, 54: 539-542. 10.1136/hrt.54.5.539CrossRefPubMedPubMedCentral Symons C, Fortune F, Greenbaum RA, Dandona P: Cardiac hypertrophy, hypertrophic cardiomyopathy and hyperparathyroidism – an association. Br Heart J 1985, 54: 539-542. 10.1136/hrt.54.5.539CrossRefPubMedPubMedCentral
16.
go back to reference Sun JR, Stewart WJ, Yang XS, Donnell RD, Leon AR, Felner JM, Thomas JD, Merlino JD: Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol 2009, 103: 411-415. 10.1016/j.amjcard.2008.09.102CrossRefPubMed Sun JR, Stewart WJ, Yang XS, Donnell RD, Leon AR, Felner JM, Thomas JD, Merlino JD: Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol 2009, 103: 411-415. 10.1016/j.amjcard.2008.09.102CrossRefPubMed
17.
go back to reference Koskenvuo JW, Engblom E, Kantola IM, Hartiala JJ, Saraste A, Kiviniemi TO, Mononen I, Saraste M: Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance. Clin Physiol Funct Imaging 2009, 29: 177-180. 10.1111/j.1475-097X.2008.00851.xCrossRefPubMed Koskenvuo JW, Engblom E, Kantola IM, Hartiala JJ, Saraste A, Kiviniemi TO, Mononen I, Saraste M: Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance. Clin Physiol Funct Imaging 2009, 29: 177-180. 10.1111/j.1475-097X.2008.00851.xCrossRefPubMed
Metadata
Title
The subaortic tendon as a mimic of hypertrophic cardiomyopathy
Author
James Ker
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2009
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-7-31

Other articles of this Issue 1/2009

Cardiovascular Ultrasound 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.